Cereno Scientific announces changes in the executive management team strengthening skill set and capabilities in preparation for expanded clinical portfolio
Cereno Scientific (XSAT: CRNO B) today announced changes to the company’s executive management team with the expansion of Dr. Björn Dahlöf’s role and the appointment of a Head of IR & Communications. Dr. Björn Dahlöf has been the company’s Chief Medical Officer (CMO) since 2018 and is now also stepping into the roles Chief Scientific Officer (CSO) and Head of Clinical Development. Josefine Göranson will join as the Head of IR & Communications. These changes will strengthen the skill set of the executive management team and heighten readiness to support the upcoming expansion of the clinical